Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Cash from Investing Activities (2016 - 2025)

Medicure has reported Cash from Investing Activities over the past 14 years, most recently at $96806.6 for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 130.19% year-over-year to $96806.6; the TTM value through Dec 2025 reached -$1.5 million, down 173.27%, while the annual FY2025 figure was -$1.5 million, 176.8% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was $96806.6 at Medicure, up from -$1.2 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $96806.6 in Q4 2025 and troughed at -$1.6 million in Q4 2021.
  • A 5-year average of -$305308.7 and a median of -$84678.7 in 2023 define the central range for Cash from Investing Activities.
  • On a YoY basis, Cash from Investing Activities climbed as much as 130.19% in 2025 and fell as far as 1451.84% in 2025.
  • Year by year, Cash from Investing Activities stood at -$1.6 million in 2021, then soared by 98.16% to -$30204.8 in 2022, then plummeted by 211.28% to -$94020.5 in 2023, then crashed by 241.1% to -$320700.4 in 2024, then surged by 130.19% to $96806.6 in 2025.
  • Business Quant data shows Cash from Investing Activities for MCUJF at $96806.6 in Q4 2025, -$1.2 million in Q2 2025, and -$377728.7 in Q1 2025.